FR2329668B1 - - Google Patents

Info

Publication number
FR2329668B1
FR2329668B1 FR7532815A FR7532815A FR2329668B1 FR 2329668 B1 FR2329668 B1 FR 2329668B1 FR 7532815 A FR7532815 A FR 7532815A FR 7532815 A FR7532815 A FR 7532815A FR 2329668 B1 FR2329668 B1 FR 2329668B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7532815A
Other versions
FR2329668A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FR7532815A priority Critical patent/FR2329668A1/fr
Publication of FR2329668A1 publication Critical patent/FR2329668A1/fr
Application granted granted Critical
Publication of FR2329668B1 publication Critical patent/FR2329668B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7532815A 1975-10-27 1975-10-27 Procede de preparation d'aminotriazolobenzodiazepines Granted FR2329668A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7532815A FR2329668A1 (fr) 1975-10-27 1975-10-27 Procede de preparation d'aminotriazolobenzodiazepines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7532815A FR2329668A1 (fr) 1975-10-27 1975-10-27 Procede de preparation d'aminotriazolobenzodiazepines

Publications (2)

Publication Number Publication Date
FR2329668A1 FR2329668A1 (fr) 1977-05-27
FR2329668B1 true FR2329668B1 (fr) 1979-07-27

Family

ID=9161688

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7532815A Granted FR2329668A1 (fr) 1975-10-27 1975-10-27 Procede de preparation d'aminotriazolobenzodiazepines

Country Status (1)

Country Link
FR (1) FR2329668A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
WO2011143660A2 (fr) 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Compositions et méthodes de traitement de la leucémie
BR112012029005A2 (pt) 2010-05-14 2016-07-26 Dana Farber Cancer Inst Inc composições e métodos de tratamento de neoplasia, doença inflamatória e outros distúrbios
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
WO2015013635A2 (fr) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibiteurs des facteurs de transcription et leurs utilisations
CA2929652A1 (fr) 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Polytherapie pour le traitement du cancer utilisant des inhibiteurs de proteine a bromodomaine et a domaine extra-terminal (bet)
RU2016134947A (ru) 2014-01-31 2018-03-01 Дана-Фарбер Кансер Институт, Инк. Производные диаминопиримидин бензолсульфона и их применение
JP2017504651A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジアゼパン誘導体の使用
WO2015131113A1 (fr) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Traitement de troubles associés à l'hyperinsulinémie
JP2017525759A (ja) 2014-08-08 2017-09-07 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジヒドロプテリジノン誘導体およびその使用
RU2017104897A (ru) 2014-08-08 2018-09-10 Дана-Фарбер Кэнсер Инститьют, Инк. Производные диазепана и их применения
BR112017008714A2 (pt) 2014-10-27 2017-12-19 Tensha Therapeutics Inc inibidores de bromodomínio
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
US11306105B2 (en) 2015-09-11 2022-04-19 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
SG10202007099TA (en) 2015-09-11 2020-08-28 Dana Farber Cancer Inst Inc Acetamide thienotriazoldiazepines and uses thereof
CN114957291A (zh) 2015-11-25 2022-08-30 达纳-法伯癌症研究所股份有限公司 二价溴结构域抑制剂及其用途

Also Published As

Publication number Publication date
FR2329668A1 (fr) 1977-05-27

Similar Documents

Publication Publication Date Title
FR2309675B3 (fr)
AU7818975A (fr)
JPS51144214U (fr)
BG22526A1 (fr)
BG21722A1 (fr)
BG22010A1 (fr)
BG22028A1 (fr)
BG22115A1 (fr)
BG22272A1 (fr)
BG23043A1 (fr)
BG23245A1 (fr)
BG23370A1 (fr)
CH201875A4 (fr)
CH376676A4 (fr)
CH577352A5 (fr)
CH581992A5 (fr)
CH582969A5 (fr)
CH585141A5 (fr)
CH586398A5 (fr)
CH586413B5 (fr)
CH586595A5 (fr)
CH586820A5 (fr)
CH588312A5 (fr)
CH592391A5 (fr)
CH592404A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse